Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
26M
-
Shares change
-
+63.2K
-
Total reported value, excl. options
-
$477M
-
Value change
-
+$545K
-
Number of buys
-
59
-
Number of sells
-
-60
-
Price
-
$18.32
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2021
142 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26M shares
of 46.4M outstanding shares and own 56.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.38M shares), FEDERATED HERMES, INC. (3.44M shares), VANGUARD GROUP INC (2.55M shares), DIMENSIONAL FUND ADVISORS LP (1.69M shares), STATE STREET CORP (1.4M shares), Invesco Ltd. (934K shares), GOLDMAN SACHS GROUP INC (719K shares), GEODE CAPITAL MANAGEMENT, LLC (660K shares), NORTHERN TRUST CORP (460K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (398K shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.